Korsana Biosciences, Inc. (KRSA)
30.43
-0.13
(-0.43%)
USD |
NASDAQ |
Nov 05, 16:00
30.43
0.00 (0.00%)
After-Hours: 07:08
Korsana Biosciences SG&A Expense (TTM) : 7.127M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.127M |
| March 31, 2026 | 7.065M |
| December 31, 2025 | 6.088M |
| September 30, 2025 | 5.992M |
| June 30, 2025 | 5.70M |
| March 31, 2025 | 5.27M |
| December 31, 2024 | 5.342M |
| September 30, 2024 | 5.865M |
| June 30, 2024 | 6.755M |
| March 31, 2024 | 7.002M |
| December 31, 2023 | 8.131M |
| September 30, 2023 | 9.639M |
| June 30, 2023 | 10.61M |
| March 31, 2023 | 12.61M |
| December 31, 2022 | 13.86M |
| September 30, 2022 | 14.99M |
| June 30, 2022 | 16.49M |
| March 31, 2022 | 19.21M |
| Date | Value |
|---|---|
| December 31, 2021 | 20.62M |
| September 30, 2021 | 23.47M |
| June 30, 2021 | 26.90M |
| March 31, 2021 | 27.29M |
| December 31, 2020 | 28.82M |
| September 30, 2020 | 28.94M |
| June 30, 2020 | 28.02M |
| March 31, 2020 | 30.32M |
| December 31, 2019 | 34.40M |
| September 30, 2019 | 35.47M |
| June 30, 2019 | 36.14M |
| March 31, 2019 | 34.74M |
| December 31, 2018 | 27.54M |
| September 30, 2018 | 22.37M |
| June 30, 2018 | 18.94M |
| March 31, 2018 | 11.41M |
| December 31, 2017 | 7.638M |
| September 30, 2017 | 4.352M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Q32 Bio, Inc. | 13.91M |
| IRulya Therapeutics, Inc. | 27.81M |
| Climb Bio, Inc. | 22.86M |
| PepGen Inc. | 23.44M |
| Bridgebio Oncology Therapeutics, Inc. | 36.80M |